This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Clinical Data Disclosure, Transparency and Plain Language Summaries
19 - 20 March, 2024
Hilton Philadelphia at Penn's Landing, PhiladelphiaHybrid Event I Attend Live In-Person or Online

Julie Holtzople
Independent Consultant at Former Head of Clinical Transparency and Data Sharing at AstraZeneca


Julie Holtzople was the Head of Clinical Transparency and Data Sharing for AstraZeneca. Prior to joining AstraZeneca, Julie worked as a management consultant for Ernst & Young and Booz Allen Hamilton. As a consultant Julie focused in the Health Care industry to deliver systems, process improvement initiatives, change management, and program management. As Head of Clinical Transparency and Data Sharing, Julie is accountable for AstraZeneca’s Trial Results Summary program, delivery of anonymized clinical documents for Health Canada’s PRCI process and similar regulations, and AstraZeneca’s process for external data sharing with researchers. As part of her role, Julie is actively involved in several industry organizations that are focused on implementing best practices within the Clinical Trial Transparency space, including Transcelerate, Pharma, Efpia and Phuse.

Agenda Sessions

  • Impact of Evolving EU Health Data Sharing Requirements on Transparency Efforts

  • PANEL Outsource vs. Develop Internally: How are Sponsors Meeting Mounting Disclosure Requirements?